Named Patient Program (Ikris Pharma Network)

Named Patient Program (NPP), a division of Ikris Pharma Network, facilitates the legal, prescription-gated import of medicines that are approved abroad but not yet available in India. We source directly from manufacturers and authorized distributors and manage GDP-compliant cold-chain logistics, including ambient, refrigerated and frozen storage with 24/7 temperature monitoring, to deliver high-cost specialty oncology, hematology, rare disease and other critical-care medicines safely to patients across India. Our process covers compliance document review, transparent pricing and timelines, regulatory approval management, and traceable cold-chain delivery. Headquartered in Noida, Uttar Pradesh, NPP is part of the Ikris group of pharma brands, which also includes IGM, IPN and Ikris Health+.